| Regency Grande Nurs & Rehab Ce | |
| 65 North Sussex Street, Dover, New Jersey 07801 | |
| (973) 361-5200 | |
| Name | Regency Grande Nurs & Rehab Ce |
|---|---|
| Location | 65 North Sussex Street, Dover, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 155 |
| Occupancy Rate | 89.42% |
| Medicare ID (CCN) | 315355 |
| Legal Business Name | Regency Grande Nursing And Rehabilitation Center Llc |
| Ownership Type | For Profit - Limited Liability Company |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Like exposure to too much sun and drinking alcohol, obesity is a risk factor for cancer. Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center are working to be a part of the solution - they want to find ways to reverse obesity-linked biological changes in the body that are associated with cancer growth.
The timing of the onset of puberty is linked to levels of nutrition: later onset is associated with malnutrition, while earlier onset is linked to childhood obesity. A team of researchers, led by Carol Elias, at the University of Texas Southwestern Medical Center, Dallas, has now generated data in mice that run counter to current thinking about the molecular pathway by which nutrition status affects the onset of puberty. Further, the team defines a new regulatory pathway for the process, which, if confirmed in humans, could potentially lead to new approaches to treating disorders of puberty and fertility.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
Women with suspected coronary artery disease and smaller social networks die at twice the rate of those who have a larger circle of social contacts, according to a new study.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.71 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.69 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 31.96 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.4 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.54 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.32 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.76 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 4.74 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.44 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.93 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 44.91 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 4.4 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.03 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.82 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.34 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.09 | 82.93 |
News Archive
Like exposure to too much sun and drinking alcohol, obesity is a risk factor for cancer. Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center are working to be a part of the solution - they want to find ways to reverse obesity-linked biological changes in the body that are associated with cancer growth.
The timing of the onset of puberty is linked to levels of nutrition: later onset is associated with malnutrition, while earlier onset is linked to childhood obesity. A team of researchers, led by Carol Elias, at the University of Texas Southwestern Medical Center, Dallas, has now generated data in mice that run counter to current thinking about the molecular pathway by which nutrition status affects the onset of puberty. Further, the team defines a new regulatory pathway for the process, which, if confirmed in humans, could potentially lead to new approaches to treating disorders of puberty and fertility.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
Women with suspected coronary artery disease and smaller social networks die at twice the rate of those who have a larger circle of social contacts, according to a new study.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 5 days ago
Dwelling Place At St Clares Location: 400 West Blackwell St, Dover, New Jersey 07801 Phone: (973) 989-3500 | |
Regency Grande Nurs & Rehab Ce Location: 65 North Sussex Street, Dover, New Jersey 07801 Phone: (973) 361-5200 |